Cognitive functioning in progressive myoclonus epilepsy type 1 (Unverricht-Lundborg Disease, EPM1)
- PMID: 34171687
- DOI: 10.1016/j.yebeh.2021.108157
Cognitive functioning in progressive myoclonus epilepsy type 1 (Unverricht-Lundborg Disease, EPM1)
Abstract
Objective: The aim of this neuropsychological study of a large cohort of patients with progressive myoclonus epilepsy type 1 (Unverricht-Lundborg disease, EPM1) was to characterize the cognitive function of EPM1 patients and to explore the association between the disability caused by the disease and cognitive performance.
Method: Sixty-eight genetically verified EPM1 patients homozygous for the expansion mutation in the CSTB gene (37 males and 31 females aged 35 ± 11) participated in a neuropsychological assessment of intellectual ability, verbal memory, and executive and psychomotor function. The clinical evaluation comprised administering (and video-recording) the unified myoclonus rating scale (UMRS) to assess the severity of each patient's myoclonus. Forty-six healthy volunteers (19 males and 27 females aged 32 ± 11) served as the control group for the neuropsychological tests.
Results: The cognitive performance of the EPM1 patient group was impaired. Verbal Intelligence Quotient (VIQ) was below the average range (VIQ < 85) in 49% of the patients; further, Performance Intelligence Quotient (PIQ) was below average in 75% of the patients. The patients performed worse than the controls in both immediate and delayed story recall (p = 0.001); however, in the word list learning task, the patients performed only slightly worse than the controls. The one-hour delayed recall of the learned words was similar in both groups, and the percentage of retained words and story contents did not differ between the patients and controls. The patients were impaired in all of the executive function tests as well as in the psychomotor speed tests (p < 0.001 for all). Also, the patients' simple psychomotor speed in the tapping task was significantly slowed in comparison to controls (p < 0.001).
Conclusion: The patients had impaired performance in the majority of the cognitive measures; they showed the highest level of impairment in all the executive function tests and in the psychomotor speed tests. The measures of these cognitive domains are timed-therefore, it is clear that severe myoclonus limits patients' performance. In contrast, verbal memory, especially delayed recall, was the least affected cognitive domain.
Keywords: Cognition; Neuropsychology; Progressive myoclonus epilepsy; Unverricht-Lundborg disease.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.Neurodegener Dis. 2011;8(6):515-22. doi: 10.1159/000323470. Epub 2011 Jul 15. Neurodegener Dis. 2011. PMID: 21757863
-
Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.Neurology. 2015 Apr 14;84(15):1529-36. doi: 10.1212/WNL.0000000000001466. Epub 2015 Mar 13. Neurology. 2015. PMID: 25770194
-
Abnormal motor cortical adaptation to external stimulus in Unverricht-Lundborg disease (progressive myoclonus type 1, EPM1).J Neurophysiol. 2018 Aug 1;120(2):617-623. doi: 10.1152/jn.00063.2018. Epub 2018 May 9. J Neurophysiol. 2018. PMID: 29742025
-
Progressive Myoclonus Epilepsy: Unverricht-Lundborg Disease.In: Noebels JL, Avoli M, Rogawski MA, Vezzani A, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies. 5th edition. New York: Oxford University Press; 2024. Chapter 51. In: Noebels JL, Avoli M, Rogawski MA, Vezzani A, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies. 5th edition. New York: Oxford University Press; 2024. Chapter 51. PMID: 39637163 Free Books & Documents. Review.
-
Clinical picture of EPM1-Unverricht-Lundborg disease.Epilepsia. 2008 Apr;49(4):549-56. doi: 10.1111/j.1528-1167.2008.01546.x. Epub 2008 Mar 5. Epilepsia. 2008. PMID: 18325013 Review.
Cited by
-
ILAE Genetics Literacy series: Progressive myoclonus epilepsies.Epileptic Disord. 2023 Oct;25(5):670-680. doi: 10.1002/epd2.20152. Epub 2023 Sep 6. Epileptic Disord. 2023. PMID: 37616028 Free PMC article. Review.
-
Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances.Genes (Basel). 2024 Jan 27;15(2):171. doi: 10.3390/genes15020171. Genes (Basel). 2024. PMID: 38397161 Free PMC article.
-
Cystatin B deficiency results in sustained histone H3 tail cleavage in postnatal mouse brain mediated by increased chromatin-associated cathepsin L activity.Front Mol Neurosci. 2022 Nov 30;15:1069122. doi: 10.3389/fnmol.2022.1069122. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36533126 Free PMC article.
-
Comorbidities in patients with Unverricht-Lundborg disease (EPM1).Acta Neurol Scand. 2022 Nov;146(5):690-693. doi: 10.1111/ane.13706. Epub 2022 Sep 13. Acta Neurol Scand. 2022. PMID: 36097839 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous